Talk:Assessment of the health impacts of H1N1 vaccination/Group D

Pandemrix should not be used because of narcolepsy risk

How to read discussions

Statements: Pandemrix should not be used any more anywhere because its narcolepsy risk is too high. NOTE! The time of the statement is September 2010. Resolution: Resolution not yet found. (A stable resolution, when found, should be updated to the main page.)

Argumentation: ⇤1 : Despite risks, Pandemrix is an effective vaccine and has clearly net positive effects in countries where emergency treatment is poorly available for severe swine flu cases. --Jouni 23:05, 31 March 2011 (EEST) ⇤# : Side effects are still there and will be treated poorly in these countries --Carmen Gil 11:25, 1 April 2011 (EEST) --# : The decision to use Pandemrix was probably led by panic and other choices should be considered at this point --Carmen Gil 11:25, 1 April 2011 (EEST) ←# : Finland used a vaccination with additives, against the recommendation of WHO --Carmen Gil 11:25, 1 April 2011 (EEST) →# : Additives can cause flu-like symptoms, increasing the public's opinion against vaccination --Carmen Gil 11:25, 1 April 2011 (EEST) ←2 : The reputation of Pandemrix is globally so poor that it is impossible to use it any more. --Jouni 23:05, 31 March 2011 (EEST) ←3 : In Finland, THL decided to stop the use of Pandemrix. --Jouni 23:05, 31 March 2011 (EEST), [1] ⇤# : Pandemrix has a lower Hg content than other vaccines (2.5 vs 25 µg), which could cause other neurological problems in children --Carmen Gil 11:25, 1 April 2011 (EEST)

• Evolution of a pandemic, World Health Organization (WHO), 2009 (Report)
• [2]
• [3]